Hiroshi Wada

Osaka International Cancer Institute

Papers

1

Total Citations

10

H-Index

1

About

Hiroshi Wada is a leading figure in the surgical management of gastric cancer, with a focused expertise in minimally invasive techniques. His research primarily investigates the comparative efficacy of robotic and laparoscopic gastrectomy, aiming to refine perioperative outcomes and long-term survival for patients. Wada’s major contribution lies in providing critical, evidence-based insights into the performance and three-year survival benefits of these advanced surgical approaches, as highlighted in his most-cited 2025 study. This work, which has garnered 10 citations, offers a nuanced understanding of how robotic assistance may enhance precision and recovery without compromising oncological safety. By systematically evaluating these technologies, Wada has helped shape clinical decision-making in gastrointestinal oncology. His research is particularly valuable for surgeons and trainees seeking to navigate the evolving landscape of gastric cancer surgery, where balancing technical innovation with patient outcomes is paramount. Through his rigorous comparative analyses, Wada continues to influence best practices and drive forward the adoption of robotic gastrectomy in specialized centers.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes
10 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Osaka International Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago